Riskpilot← Back to searchSign inGet full accessMedbo och söner AB
ABActiveOrg 5592880743Idunagatan 50All other professional, scientific and technical activities n.e.c. · NACE 7499Est. 20200 employees
Revenue 2025
SEK 295K
EBITDA margin
85.1%
Equity ratio
88.5%
Financial strength
Net profit 2025
SEK 206K
0 employees
| Revenue | SEK 295K | — |
| EBITDA | SEK 251K | — |
| Net profit | SEK 206K | — |
| Total assets | SEK 574K | — |
| Equity | SEK 508K | — |
| Employees | 0 | — |
Legal name
Medbo och söner AB
Org number
5592880743
Legal form
Aktiebolag
NACE code
7499 · All other professional, scientific and technical activities n.e.c.
Founded
7 december 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Konsult- och utbildningsverksamhet med fokus på verksamheters produktion, organisation, vårdpersonalbemanning, medicinsk rådgivning och utbildning samt affärsverksamhet där medicinsk kompetens är tillämplig och därtill förenlig verksamhet. Handel med och förvaltning av värdepapper, fastigheter samt annan lös och fast egendom och därtill förenlig verksamhet
Address
Idunagatan 50
Email
lars.medbo@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 243 | 479 | 457 | — | 295 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 211 | 405 | 415 | 0 | 251 |
| Depreciation & amort. | −0 | −0 | −0 | — | −0 |
| EBIT | 211 | 405 | 415 | 0 | 251 |
| Net financials | — | — | 2 | — | 8 |
| Profit before tax | 212 | 405 | 417 | 0 | 259 |
| Tax | −44 | −85 | −86 | — | −53 |
| Net profit | 168 | 320 | 331 | — | 206 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 290 | 520 | 683 | — | 574 |
| Equity | 193 | 345 | 461 | — | 508 |
| Long-term debt | 0 | 0 | 0 | — | 0 |
| Short-term debt | 97 | 175 | 222 | — | 66 |
| Total debt | 97 | 175 | 222 | — | 66 |
EBITDA margin
85.1%
This company
15.8%
Market median
+439% vs market
20212025
Equity ratio
88.5%
This company
38.2%
Market median
+132% vs market
20212025
Return on equity
40.6%
This company
18.4%
Market median
+121% vs market
20212025
Net profit margin
69.8%
This company
8.1%
Market median
+762% vs market
20212025
Asset turnover
0.51×
This company
1.12×
Market median
-54% vs market
20212025
Debt / equity
0.13×
This company
0.62×
Market median
+79% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-12-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medbo och söner AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jakob Mikael Medbo | Board of Directors | 0 companies |
| Lars Gunnar Medbo | Chairman | 0 companies |
| Simon Viktor Medbo | Board of Directors | 0 companies |
| Marie Lomska Medbo | Deputy Board Member | 0 companies |